These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7677823)

  • 1. Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
    DeGroot LJ; Gorman CA; Pinchera A; Bartalena L; Marcocci C; Wiersinga WM; Prummel MF; Wartofsky L; Marocci C [corrected to Marcocci C]
    J Clin Endocrinol Metab; 1995 Feb; 80(2):339-40. PubMed ID: 7677823
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic controversies. Summation, commentary, and overview: concerns over aggravation of Graves' ophthalmopathy by radioactive iodine treatment and the use of retrobulbar radiation therapy.
    Wartofsky L
    J Clin Endocrinol Metab; 1995 Feb; 80(2):347-9. PubMed ID: 7852488
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic controversies. Retrobulbar radiation in Graves' ophthalmopathy.
    Wiersinga W; Prummel MF
    J Clin Endocrinol Metab; 1995 Feb; 80(2):345-7. PubMed ID: 7852487
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but...
    Pinchera A; Bartalena L; Marcocci C
    J Clin Endocrinol Metab; 1995 Feb; 80(2):342-5. PubMed ID: 7852486
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
    Gorman CA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):340-2. PubMed ID: 7852485
    [No Abstract]   [Full Text] [Related]  

  • 7. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy.
    Wiersinga WM; Smit T; Schuster-Uittenhoeve AL; van der Gaag R; Koornneef L
    Ophthalmologica; 1988; 197(2):75-84. PubMed ID: 3186212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug treatment of Graves' ophthalmopathy].
    Prummel MF; Wiersinga WM
    Ned Tijdschr Geneeskd; 1990 May; 134(19):938-40. PubMed ID: 1693417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe.
    Rosetti S; Tanda ML; Veronesi G; Masiello E; Premoli P; Gallo D; Cusini C; Donati S; Sabatino J; Ippolito S; Piantanida E; Bartalena L
    J Endocrinol Invest; 2020 Mar; 43(3):381-383. PubMed ID: 31587179
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 131 iodine therapy on the course of Graves' ophthalmopathy: a quantitative analysis of extraocular muscle volumes using orbital magnetic resonance imaging.
    Gupta MK; Perl J; Beham R; Sheeler LR; Foster JA; Gliga M; Mcbride N; Faiman MR; Mehta AE; Dattatreya R; Faiman C
    Thyroid; 2001 Oct; 11(10):959-65. PubMed ID: 11716044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular carcinoma of the thyroid following radioactive iodine treatment for Graves' disease.
    Staffurth JS; Holl-Allen RT
    Postgrad Med J; 1988 Nov; 64(757):878-80. PubMed ID: 3255938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optimal treatment for pediatric Graves' disease is radioiodine.
    Rivkees SA; Dinauer C
    J Clin Endocrinol Metab; 2007 Mar; 92(3):797-800. PubMed ID: 17341574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' disease induced by Na(131)I therapy for toxic multinodular goitre.
    van Leussen JJ; Edelbroek MA; Talsma MA; de Heide LJ
    Neth J Med; 2000 Nov; 57(5):194-7. PubMed ID: 11185482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy?
    Weetman AP; Harrison BJ
    J Endocrinol Invest; 1998; 21(7):472-5. PubMed ID: 9766265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (131)I and thyroid-associated ophthalmopathy.
    Rasmussen AK; Nygaard B; Feldt-Rasmussen U
    Eur J Endocrinol; 2000 Aug; 143(2):155-60. PubMed ID: 10913933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital radiation therapy for Graves' ophthalmopathy.
    Ainbinder DJ; Halligan JB
    Ophthalmology; 2003 Mar; 110(3):449; author reply 449-50. PubMed ID: 12623795
    [No Abstract]   [Full Text] [Related]  

  • 20. Does radioiodine cause the ophthalmopathy of Graves' disease?
    McDougall IR
    Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.